Gain Therapeutics Announces 2024 R&D Update on Parkinson's Disease with KOL & Analyst Insight streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Event, moderated by Hartaj Singh and Eka Gigauri of Oppenheimer & Co., will be held on Thursday, February 22, 2024 at 11:00 am ESTBETHESDA, Md., Feb. 14, 2024 Gain Therapeutics, Inc., , a.
/PRNewswire/ Oppenheimer & Co. Inc. (Oppenheimer) a leading investment bank, wealth manager and a subsidiary of Oppenheimer Holdings (NYSE: OPY) today.
The S&P 500 has been reaching record highs again. The strong investor sentiment has been supported by the falling rate of inflation, and expectations that the Federal Reserve will have room to cut back on interest rates this year. This has colored Oppenheimer’s chief investment strategist John Stoltzfus’ current take on the economy. “In our view ‘so far so good’ is what the economic data stateside is saying,” the strategist recently said. “While the economy has indeed shown some slowing in the f